Clinical Trials Logo

BRCA2 Gene Mutation clinical trials

View clinical trials related to BRCA2 Gene Mutation.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01905592 Terminated - Ovarian Neoplasms Clinical Trials

A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients

BRAVO
Start date: February 25, 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare progression-free survival (PFS) in patients with advanced/metastatic breast cancer who have a BRCA mutation when treated with niraparib as compared to those treated with physician's choice